Kalaris Therapeutics, Inc. (KLRS) — Cash Flow Reinvestment Rate
Kalaris Therapeutics, Inc. (KLRS) has a Cash Flow Reinvestment Rate of 0.00x as of December 2018, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $1.94 Million. See KLRS cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Kalaris Therapeutics, Inc. Cash Flow Reinvestment Rate (2018–2018)
Historical reinvestment intensity for Kalaris Therapeutics, Inc. across 1 annual periods. For the full cash flow conversion analysis, see Kalaris Therapeutics, Inc. (KLRS) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Kalaris Therapeutics, Inc. (2018–2018)
Year-by-year capital reinvestment analysis for Kalaris Therapeutics, Inc.. See KLRS free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2018 | 0.00x | $0.00 | $1.94 Million | $0.00 | — |